Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

H Uusitalo, M Kähönen, A Ropo, J Mäenpää, G Bjärnhall, H Hedenström, V. Turjanmaa

Research output: Contribution to journalArticleScientificpeer-review

Original languageUndefined/Unknown
Pages (from-to)1491-1496
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Publication statusPublished - 2006
Publication typeA1 Journal article-refereed

Cite this